XML 62 R20.htm IDEA: XBRL DOCUMENT
v3.3.0.814

Investment in Viking Therapeutics, Inc. (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Equity Method Investments | December 31, 2014 Viking's assets and liabilities which were consolidated for the period shown were as follows (in thousands):
| December 31, 2014
Cash and cash equivalents | $ | 756 |
Other current assets | 18 |
Capitalized IPO expenses | 2,268 |
Total current assets | $ | 3,042 |
Other assets | $ | 1 |
Total assets | $ | 3,043 |
Accounts payable | $ | 2,211 |
Accrued liabilities | 77 |
Current portion of notes payable | 334 |
Total current liabilities | $ | 2,622 |
Long-term portion of notes payable | 2,331 |
Total liabilities | $ | 4,953 |

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration